These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8422230)

  • 1. Improved liver function following treatment with an extracorporeal liver assist device.
    Sussman NL; Kelly JH
    Artif Organs; 1993 Jan; 17(1):27-30. PubMed ID: 8422230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device.
    Sussman NL; Finegold MJ; Barish JP; Kelly JH
    Am J Gastroenterol; 1994 Jul; 89(7):1077-82. PubMed ID: 7517100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.
    Kelly JH; Sussman NL
    ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of fulminant hepatic failure using an extracorporeal liver assist device.
    Sussman NL; Chong MG; Koussayer T; He DE; Shang TA; Whisennand HH; Kelly JH
    Hepatology; 1992 Jul; 16(1):60-5. PubMed ID: 1618484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular adsorbent recirculating system and bioartificial devices for liver failure.
    Bañares R; Catalina MV; Vaquero J
    Clin Liver Dis; 2014 Nov; 18(4):945-56. PubMed ID: 25438293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver assist devices (LADs) will not be used to treat fulminant hepatic failure (FHF), but its consequences, namely hepatic encephalopathy (HE).
    Sussman NL; Kelly JH
    Artif Organs; 1993 Jan; 17(1):43-5. PubMed ID: 8422234
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.
    Rozga J; Podesta L; LePage E; Hoffman A; Morsiani E; Sher L; Woolf GM; Makowka L; Demetriou AA
    Lancet; 1993 Oct; 342(8876):898-9. PubMed ID: 8105168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of a hollow fiber liver assist device.
    Jauregui HO; Mullon CJ; Trenkler D; Naik S; Santangini H; Press P; Muller TE; Solomon BA
    Hepatology; 1995 Feb; 21(2):460-9. PubMed ID: 7843721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal liver support. Application to fulminant hepatic failure.
    Sussman NL; Gislason GT; Kelly JH
    J Clin Gastroenterol; 1994 Jun; 18(4):320-4. PubMed ID: 8071519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson KJ; Koutalistras N; Wang LS
    Aust N Z J Surg; 1996 Aug; 66(8):547-52. PubMed ID: 8712990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal liver assist in the treatment of fulminant hepatic failure.
    Sussman NL; Kelly JH
    Blood Purif; 1993; 11(3):170-4. PubMed ID: 8280439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On bioartificial liver assist system: theoretical exploration and strategies for further development.
    Shi Q
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):535-46. PubMed ID: 11063094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial liver support.
    Sussman NL; Kelly JH
    Clin Invest Med; 1996 Oct; 19(5):393-9. PubMed ID: 8889280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioartificial liver used as a bridge to liver transplantation in a 10-year-old boy.
    LePage EB; Rozga J; Rosenthal P; Watanabe F; Scott HC; Talke AM; Demetriou AA
    Am J Crit Care; 1994 May; 3(3):224-7. PubMed ID: 8038852
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant hepatic failure due to allopurinol.
    Raper R; Ibels L; Lauer C; Barnes P; Lunzer M
    Aust N Z J Med; 1984 Feb; 14(1):63-5. PubMed ID: 6590011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hepatix extracorporeal liver assist device: initial clinical experience.
    Sussman NL; Gislason GT; Conlin CA; Kelly JH
    Artif Organs; 1994 May; 18(5):390-6. PubMed ID: 8037614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report.
    Adachi Y; Kinoshita O; Hatano M; Shintani Y; Naito N; Kimura M; Nawata K; Nitta D; Maki H; Ueda K; Amiya E; Takimoto E; Komuro I; Ono M
    J Med Case Rep; 2017 Oct; 11(1):295. PubMed ID: 29061186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An artificial liver on its way to clinical reality?].
    Thasler WE; Koebe HG; Pahernik SA; Schildberg FW
    Zentralbl Chir; 1995; 120(8):614-23. PubMed ID: 7571893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.